Bone Marrow Aspirate Concentrate for Anterior Cruciate Ligament Tear Treatment.

Recruiting now · Not applicable

Conditions studied: Anterior Cruciate Ligament Tear

In brief

A single armed multicenter study enrolling 20 patients using autologous bone marrow aspirate concentrate (which is done under local or general anesthesia to aspirate around 1-2 cc/kg body weight then concentration which is done by using centrifugation and special disposable kit) local injection of 4 cc per joint under ultrasonic guidance ,completely sterile field with local anesthesia.

Key facts

Study ID

NCT06353503

Run by

abdulmajeed hammadi

People needed

20

Starts

2024-04-02

Expected to finish

2026-09-27

Last updated by the study team

2025-08-07

Who can join

Age: 20 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 1- Confirmed diagnosis of complete or partial ACL tear via clinical examination and imaging studies.
• Aged between 20 and 55 years, to encompass the typical age range of patients with sports-related ACL injuries.

You may not qualify if…

• 1- Patients with a history of bleeding disorders, as this could complicate the aspiration and injection procedures.
• Individuals with a history of malignancy, due to the potential risks associated with growth factors present in BMAC.
• Critically ill patients or those with comorbidities

Where it is running

• Ministry of Health — Baghdad, Iraq (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.